Bifemelane

This classification denotes an antidepressive agent with the molecular formula C18H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z4501GN13G, chemically known as 1-butanamine, n-methyl-4-(2-(phenylmethyl)phenoxy)-, hydrochloride but generally known as bifemelane, which bears US NIH Compound Identifier 2377. Bifemelane most often comes in base and hydrochloride forms. European Medicines Agency schedules Bifemelane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05827MIG. World Health Organization schedules bifemelane in its Anatomical Therapeutic Chemical (ATC) Classification. BIFEMELANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bifemelane under HS 29221980 and SITC 51461. As of Q4 2014, BIFEMELANE remains the US FDA Preferred Term for this commodity. SMILES: O(CCCCNC)c1c(Cc2ccccc2)cccc1.